Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anthony, Stephanou"'
Publikováno v:
Oncotarget
Our previous genome-wide association study identified the anti-tumor ligand MHC class I polypeptide-related sequence A (MICA) as a susceptibility gene for hepatitis C virus-induced hepatocellular carcinoma (HCC). We subsequently proved that pharmacol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06764b6f3c592a96e4316be5b44d04da
https://doi.org/10.18632/oncotarget.24568
https://doi.org/10.18632/oncotarget.24568
Autor:
Ryosuke Muroyama, Hitoshi Yoshida, Naoya Kato, Yoshimi Kaise, Yasuo Matsubara, Kaku Goto, Sayuri Morimoto, Lay Ahyoung Lim, Ryo Nakagawa, Anthony Stephanou, Jun Arai, Sayaka Ito, Yasushi Tanoue
Publikováno v:
Journal of Gastroenterology and Hepatology. 33:1075-1081
Background and Aim The multi-kinase inhibitor regorafenib (REG) was recently demonstrated to be effective in patients with sorafenib (SOR)-resistant hepatocellular carcinoma (HCC). Interestingly, SOR is known to enhance the accumulation of membrane-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ec8d72f64cb14e3a6caca74770ecaa
https://doi.org/10.1111/jgh.14029
https://doi.org/10.1111/jgh.14029
Autor:
Jun, Arai, Kaku, Goto, Anthony, Stephanou, Yasushi, Tanoue, Sayaka, Ito, Ryosuke, Muroyama, Yasuo, Matsubara, Ryo, Nakagawa, Sayuri, Morimoto, Yoshimi, Kaise, Lay Ahyoung, Lim, Hitoshi, Yoshida, Naoya, Kato
Publikováno v:
Journal of gastroenterology and hepatology. 33(5)
The multi-kinase inhibitor regorafenib (REG) was recently demonstrated to be effective in patients with sorafenib (SOR)-resistant hepatocellular carcinoma (HCC). Interestingly, SOR is known to enhance the accumulation of membrane-bound MHC class I po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69c133194f65e4140374aedcbd476516
https://pubmed.ncbi.nlm.nih.gov/29055152
https://pubmed.ncbi.nlm.nih.gov/29055152